← Back to patent-cliff list
CAS 690636-28-3
4-(2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine
Codes: KX-01-003
Application context (from source-drug indications)
Actinic keratosisTirbanibulin角化病TirbanibulinBasal cell carcinomaTirbanibulinObesityTirbanibulinInsulin resistanceTirbanibulinPsoriasisTirbanibulin
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Tirbanibulin | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-morpholinoethan-1-ol→4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol→4-(2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine→N-benzyl-2-(5-bromopyridin-2-yl)acetamide→5-(5-bromopyridin-2(1H)-ylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.